// App-Quantinova.ai

OP118 : Multicentre evaluation of the novolimus-eluting, fully bioresorbable coronary scaffold: two-year clinical and longer-term imaging endpoints

Researchers

Presenter

  • Abizaid A

Principal Investigators

  • Schofer J

  • Maeng M

  • Yan J

  • Bhat V

  • Toyloy S

  • Morrison L

  • Verheye S

  • Ormiston J

  • Witzenbichler B

  • Botelho R

  • Costa R

  • Costa J.R

  • Chamie D

  • Polachini De Castro J

Medical Centers

  • Cardiovascular Research Center, Sao Paulo, Brazil

  • Instituto Do Coracao Do Triangulo Mineiro, Uberlandia, Brazil

  • Charite Benjamin Franklin Campus, Berlin, Germany

  • ZNA Middelheim, Antwerp, Belgium

  • Auckland City Hospital, Auckland, New Zealand

  • Aarhus university Hospital/Skejby, Skejby, Denmark

  • Dante Pazzanese, Sao Paulo, Brazil

  • Universitares Herz- und Gefasszentrum, Hamburg, Germany

Locations

  • Brazil

  • Germany

  • Denmark

  • Belgium

  • New Zealand

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Coronary artery lesions

  • Venous thrombosis

Biomarkers

  • Serine/threonine-protein kinase mTOR

Drug/Treatment

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved